OTC Markets OTCPK - Delayed Quote
USD
Noveris Health Sciences Inc. (MYCOF)
0.8000
+0.0700
(+9.59%)
As of October 30 at 4:00:00 PM EDT. Market Open.
Loading chart for MYCOF
- Previous Close
0.7300 - Open
0.8000 - Bid 1.1500 x --
- Ask 2.0000 x 20000
- Day's Range
0.8000 - 0.8000 - 52 Week Range
0.0960 - 2.0400 - Volume
1,000 - Avg. Volume
156 - Market Cap (intraday)
46.838M - Beta (5Y Monthly) -5.75
- PE Ratio (TTM)
0.42 - EPS (TTM)
1.8900 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
MYCOF
266.97%
S&P/TSX Composite index (^GSPTSE)
12.88%
1-Year Return
MYCOF
238.98%
S&P/TSX Composite index (^GSPTSE)
18.87%
3-Year Return
MYCOF
82.22%
S&P/TSX Composite index (^GSPTSE)
83.28%
5-Year Return
MYCOF
99.86%
S&P/TSX Composite index (^GSPTSE)
69.92%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-115.47%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
1.64M
-
Diluted EPS (ttm)
1.8900
Balance Sheet and Cash Flow
-
Total Cash (mrq)
808.97k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-6.19M
